Auron Therapeutics Closes $12.75 Million Seed Financing to Develop Differentiation Therapies for Treatment of Cancers

NEXT STORY
Vaxart Announces Publication of a Peer-reviewed Journal Article Showing the Potential Clinical and Economic Value of a Norovirus Vaccine
PREV STORY
Vaxil Provides Update on USAMRIID, Oral Experiment and Other General Business Matters
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Paratek Pharmaceuticals to Present at the H.C. Wainwright Annual Global Life Sciences Conference

BOSTON, March 28, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK) today announced that ...

author_avatar
NASDAQ Market News

Pfizer and BioNTech Initiate Rolling Submission of Supplemental Biologics License Application to U.S. FDA for Booster Dose of COMIRNATY® in Individuals 16 and Older

author_avatar
NASDAQ Market News

PDS Biotechnology to Present at the Benzinga Healthcare Conference

author_avatar
NASDAQ Market News